Ann: RAP Licenses Additional Pneumonia Diagnostic from UniQuest, page-173

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 173 Last

Share
Profile

Follow
vwboy

5,645 Posts.

365

04/05/17

11:27

Post #: 24465552
Share

Originally posted by Wise_One ↑

I feel many are underestimating the commercialisation / integration risk that this tech may have. Integrating in to a major telehealth / insurance company may take many months of trials & coding of APIs etc to get it right. (I'm not saying it WILL - I'm saying it MAY)

All the while, there will be no revenue flowing through the door & the quarterly burn is c. $2.5m

A good comparison (from an integration perspective) may be to CR8. They're trying to integrate their AI in to the largest insurance company in the US & its taking much longer than anticipated & the SP has been smashed from 10c to 3c as the insurance company's security requirements are extremely onerous.

The comparison is apt given both companies are trying to integrate with insurers in the states & both have digital solutions.

The telehealth / insurers will want to ensure there is absolutely zero litigation risk for themselves given the US is the most litigious jurisdiction in the world.

I don't for a second doubt the results from the upcoming US trials will be nothing less than spectacular - however that wont mean immediate $ flowing through the door & all the while they're burning c. $2.5m/Qtr

Worthy of a consideration at least.

Expand

You know your gunna cop an a s s whooping again haha

RAP Price at posting: 30.5¢ Sentiment: Buy Disclosure: Held
7 Upvote

0 Great analysis

Reply

Top Stories

TVN

Tivan to kick off maiden drilling for lead and silver at Sandover, NT, in Q4 CY24

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

SPQ

Superior finds multi-lode shoot system at QLD's Steam Engine gold play

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

There are more pages in this discussion • 34 more messages in this thread...

First 173 Last

Add RAP (ASX) to my watchlist

Ann: RAP Licenses Additional Pneumonia Diagnostic from UniQuest, page-173

Top Stories

Tivan to kick off maiden drilling for lead and silver at Sandover, NT, in Q4 CY24

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Superior finds multi-lode shoot system at QLD's Steam Engine gold play

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News